Jan 16, 2020 / 04:30PM GMT
K. Gong - JP Morgan Chase & Co, Research Division - Analyst
Okay. Welcome to the last day of the JPMorgan Healthcare Conference. My name is Allen Gong. I'm on the Medical Supplies and Devices team here at JPMorgan.
It's my pleasure today to introduce the President and CEO of Inogen, Scott Wilkinson; and the CFO, Ali Bauerlein. After the prepared remarks, the breakout session will be down the hall and then around the corner in the Olympic Room.
Scott Wilkinson - Inogen, Inc. - CEO, President & Director
Thank you. I'd like to begin as I usually do by just saying thank you to JPMorgan for inviting us to the 38th Annual Health Care Conference. It's always a pleasure to get up and speak with investors and tell our Inogen story. We're always thankful for that opportunity, and we're thankful for the opportunity today.
Our name, Inogen, stands for innovation in oxygen therapy. And I think you'll find as we go through the overview of our company and look at not only our product solutions but also our go-to-market strategy that, that name is
Inogen Inc at JPMorgan Healthcare Conference Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |

30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 

4.6 out of 5
Trustpilot
